Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.62 USD | +3.12% | -9.59% | +9.48% |
Apr. 25 | Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer | RE |
Apr. 22 | Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court | MT |
Business Summary
Number of employees: 203
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies
100.0
%
| 254 | 100.0 % | 193 | 100.0 % | -24.27% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 254 | 100.0 % | 193 | 100.0 % | -24.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 02-10-31 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 12-11-30 |
Scott Howell
HRO | Human Resources Officer | - | 19-07-31 |
Kim Wijkstrom
SAM | Sales & Marketing | 57 | 19-08-20 |
Tim Williams
LAW | General Counsel | 48 | 18-08-12 |
Corporate Officer/Principal | 55 | 03-05-31 | |
Corporate Officer/Principal | 73 | 05-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 05-11-30 |
Chief Executive Officer | 64 | 02-10-31 | |
Director/Board Member | 72 | 20-02-13 | |
Director/Board Member | 52 | 19-10-27 | |
Phaedra Chrousos
BRD | Director/Board Member | 44 | 19-04-23 |
Tage Honoré
BRD | Director/Board Member | - | 23-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,537,499 | 54,541,643 ( 94.79 %) | 0 | 94.79 % |
Company contact information
Vanda Pharmaceuticals, Inc.
2200 Pennsylvania Avenue NW Suite 300E
20037, Washington
+202 734 3400
http://www.vandapharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.48% | 266M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VNDA Stock
- Company Vanda Pharmaceuticals Inc.